- 英文名称
- (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-9-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate trihydrate
- 分子式
- C43H59NO17
- 分子量
- 861.93
- 中文别名
- Docetaxel trihydrate; Xrp6976; Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6, 11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-, hydrate (1:3); Unii-15H5577cqd; (2α,5β,7β,10β,13α)-4-Acetoxy-1,7,10-trihydroxy-13-{[(2R,3S)-2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate trih 
 ydrate; docetaxel trihydrate; DOCETAXEL HYDRATE; (1β,2α,5β,7β,10β,13α)-4-Acetoxy-1,7,10-trihydroxy-13-{[(2R,3S)-2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoat e trihydrate; Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (2aR,4S,4aS,6R,9S,11R,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6, 11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-, hydrate (1:3); Docetaxel (Trihydrate)
- 用途
- 生命科学；医药，抗肿瘤植物药，用于转移性乳腺癌和非小细胞肺癌的治疗；作为有机合成中间体和医药中间体，主要用于实验室研发过程和化工医药合成过程中，作为抗癌药物的合成中间体。Docetaxel是microtubules解聚抑制剂，通过结合于稳定的微管发挥作用，体外抑制人癌细胞Hs746T、AGS、HeLa、CaSki、BxPC3、Capan-1的克隆存活，抑制HUVEC迁移及血管生成因子刺激的HUVEC趋药性，诱导人单核细胞表达PGHS-2；体内可抑制结肠癌异种移植瘤生长，抑制血管生成反应。
